Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of ...

Unlike the HeLa cell line named after her, Henrietta Lacks was little heard of until the 2010 publication of Rebecca Skloot’s book, The Immortal Life of Henrietta Lacks. Born in 1920 in Virginia, ...

In his new role, Mr. Soleymannezhad will lead MaxCyte’s commercial operations to increase adoption of the ExPERT Platform, provide best-in-class scientific, technical and regulatory support to ...

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery ...

This valuable study reports on a novel role of PD-1 in early T cell differentiation, showing that PD-1 stimulation impairs Th2 differentiation more effectively than that of Th1, with implications for ...

Opencell Technologies, a leading innovator in scalable and continuous cell transfection technology, and Adva Biotechnology, a leader in automated innovative cell manufacturing solutions providing a ...

BLiNQ Networks and Druid Software are expanding their partnership to address the high demand in Industry 4.0 for converged 5G and Wi-Fi access. This is achieved by combining BLiNQ's PCW-400i ...

Researchers developed novel genetic tools to trace, ablate, and manipulate p16^Ink4a+^ senescent cells, revealing their ...

Now, an international team of mathematicians has discovered a new class of shapes capable of tiling with a minimal amount of sharp corners, which they define as “soft cells.” Their findings ...